SEC Filing Details
Document Details
Form
Filing Date
Mar 9, 2022
Document Date
Feb 14, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
CytomX Therapeutics, Inc.
Issuer
CytomX Therapeutics, Inc.
Filer
OGDEN CHRISTOPHER